Results 71 to 80 of about 61,104 (91)
Some of the next articles are maybe not open access.

Analysis Of Accelerometer Counts During Sedentary Activities In 5-11 Year Old Children Using a Wrist-Worn Accelerometer: 3799 Board #238 June 4, 9: 30 AM - 11: 00 AM.

Medicine & Science in Sports & Exercise, 2016
METHODS: Data from the Brazilian site of the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE) were included in the analysis. An Actigraph GT3X+ accelerometer was used to monitor MVPA over 7 days.
J. Chandler   +3 more
semanticscholar   +1 more source

The fast transient AT 2023clx in the nearby LINER galaxy NGC 3799 as a tidal disruption of a very low-mass star

Astronomy & Astrophysics
We present an extensive analysis of the optical and ultraviolet (UV) properties of AT 2023clx, the closest optical/UV tidal disruption event (TDE) to date ($z=0.01107$), which occurred in the nucleus of the interacting low-ionization nuclear emission ...
P. Charalampopoulos   +32 more
semanticscholar   +1 more source

Abstract 3799: Spatial biomarker prediction in papillary renal cell carcinoma using artificial intelligence-based immunofluorescent inference

Cancer Research
Papillary renal cell carcinoma (pRCC) accounts for ~15-20% of the global burden for kidney cancers but still lacks effective mechanisms to predict patient responses to therapeutic intervention.
Jared Brewer   +3 more
semanticscholar   +1 more source

Abstract 3799: Technical validation of a micro-flow cytometry platform for prostate cancer biomarker discovery

, 2017
The analysis of extracellular vesicles (EVs) in biofluids is an expanding area of biomarker discovery. To be effective, a diagnostic test must differentiate EVs originating from cancer cells versus non-cancerous origins, and also define biomarkers ...
D. Pink   +5 more
semanticscholar   +1 more source

Abstract 3799: The PAK4 allosteric modulator (KPT-9274) attenuates the growth of renal cell carcinoma

, 2016
Renal cell carcinoma (RCC) is an increasingly prevalent cancer type that is frequently asymptomatic on presentation and is associated with poor responses and resistance even to the current targeted therapies.
R. Weiss   +4 more
semanticscholar   +1 more source

Abstract 3799: CDKN2ALow cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistance

Cancer Research
Approximately 50% of cancers exhibit decreased CDKN2A expression (CDKN2ALow), which is linked to resistance to immune checkpoint blockade (ICB). The mechanisms driving ICB resistance due to CDKN2A loss alone remain largely unexplored.
R. Buj, K. Aird
semanticscholar   +1 more source

Abstract 3799: Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT

, 2015
Cordycepin is an adenosine analog originally extracted from Cordyceps militaris that possesses many pharmacological effects including immune activation and antioxidant and antitumor effects.
N. Kim, Gi-Young Kim, Yung-Hyun Choi
semanticscholar   +1 more source

Abstract 3799: Urokinase kringle-derived peptide UP-7 potently inhibits angiogenesis and tumor growth

, 2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA The recombinant kringle domain of urokinase-type plasminogen activator (UK1) has been shown to inhibit angiogenesis in vitro and in vivo and suppress brain tumor in vivo. UK1 consists
Hyun‐Kyung Kim   +3 more
semanticscholar   +1 more source

Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine
BACKGROUND Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence the incidence of stroke. METHODS We conducted
Rajesh K. Kharbanda   +45 more
semanticscholar   +1 more source

Abstract 3799: HTS performance and high-content analysis of antimigratory compound phenotypes using the Oris Pro 384 cell migration assay.

, 2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC The discovery of anti-metastatic agents that inhibit cancer cell motility has been hindered by a dearth of high‐throughput screening (HTS) -compatible cell motility assays.
Jennifer A. Fronczak   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy